LakeShore Biopharma Co Long Term Debt

LakeShore Biopharma Co (YS) currently reports a long-term debt of $24M as of March 2025. That compares with $100M in the prior-year period — down 76.7% year over year. Use the charts on this page to explore LakeShore Biopharma Co's long-term debt history and peer comparisons.

LakeShore Biopharma Co's long-term debt decreased from $100M to $24M — a 76.7% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LakeShore Biopharma Co reported $24M in long-term debt as of March 2025. That compares with $100M in the prior-year period — down 76.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $24M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LakeShore Biopharma Co, and consider following YS for alerts when major investors trade the stock.